The DOI matches its Crossref record.
Mortality in Children and Adolescents With Sickle Cell Disease
Abstract
A study of the natural history of sickle hemoglobinopathies was begun in March 1979. By August 1987, a total of 2824 patients <20 years of age were enrolled. There have been 14 670 person-years of followup. Seventy-three deaths have occurred. Most of the deaths were in patients with hemoglobin SS. The peak incidence of death was between 1 and 3 years of age, and the major cause in these young patients was infection. Cerebrovascular accidents and traumatic events exceeded infections as a cause of death in patients > 10 years of age. There was limited success in identifying risk factors for death. Comparison of this study's overall mortality of 2.6% (0.5 deaths per 100 person-years) with previous reports indicates improvement of survival in US patients <20 years of age with sickle hemoglobinopathies. This improvement is most likely due to parental education and counseling about the illness and the early institution of antibotics in suspected infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Self-citationPain in Sickle Cell Disease: Rates and Risk Factors
Platt, O. S., Thorington, B. D., Brambilla, D. J., Milner, P. F., Rosse, W. F., Vichinsky, E., & Kinney, T. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107043250103 · Cited by 1,546
Self-citationConnelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course
Vichinsky, E. P., Styles, L. A., Colangelo, L. H., Wright, E. C., Castro, O., Nickerson, B., & Disease, T. C. S. O. S. C. (1997) · Blood · doi:10.1182/blood.v89.5.1787 · Cited by 573
Outcome of Sickle Cell Anemia: A 4-Decade Observational Study of 1056 Patients
Powars, D. R., Chan, L. S., Hiti, A., Ramicone, E., & Johnson, C. (2005) · Medicine · doi:10.1097/01.md.0000189089.45003.52 · Cited by 558
Prediction of Adverse Outcomes in Children with Sickle Cell Disease
Miller, S. T., Sleeper, L. A., Pegelow, C. H., Enos, L. E., Wang, W. C., Weiner, S. J., Wethers, D. L., Smith, J., & Kinney, T. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001133420203 · Cited by 508
Self-citationDefinitions of the phenotypic manifestations of sickle cell disease
Ballas, S. K., Lieff, S., Benjamin, L. J., Dampier, C. D., Heeney, M. M., Hoppe, C., Johnson, C. S., Rogers, Z. R., Smith‐Whitley, K., Wang, W. C., et al. (2010) · American Journal of Hematology · doi:10.1002/ajh.21550 · Cited by 451
How I use hydroxyurea to treat young patients with sickle cell anemia
Ware, R. E. (2010) · Blood · doi:10.1182/blood-2009-04-146852 · Cited by 396
The number of people with sickle‐cell disease in the United States: national and state estimates
Brousseau, D. C., A Panepinto, J., Nimmer, M., & Hoffmann, R. G. (2010) · American Journal of Hematology · doi:10.1002/ajh.21570 · Cited by 382
Survival of children with sickle cell disease
Quinn, C. T., Rogers, Z. R., & Buchanan, G. R. (2004) · Blood · doi:10.1182/blood-2003-11-3758 · Cited by 377
Causes of death in sickle cell disease: an autopsy study
Manci, E. A., Culberson, D. E., Yang, Y., Gardner, T. M., Powell, R., Haynes, J., Shah, A. K., Mankad, V. N., & Investigators of the Cooperative Study of Sickle Cell Disease (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04594.x · Cited by 350
Mortality in Sickle Cell Anemia in Africa: A Prospective Cohort Study in Tanzania
Makani, J., Cox, S. E., Soka, D., Komba, A. N., Oruo, J., Mwamtemi, H., Magesa, P., Rwezaula, S., Meda, E., Mgaya, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014699 · Cited by 326
Factors associated with survival in a contemporary adult sickle cell disease cohort
Elmariah, H., Garrett, M. E., De Castro, L. M., Jonassaint, J. C., Ataga, K. I., Eckman, J. R., Ashley‐Koch, A. E., & Telen, M. J. (2014) · American Journal of Hematology · doi:10.1002/ajh.23683 · Cited by 300
Guidelines for the management of the acute painful crisis in sickle cell disease
Rees, D. C., Olujohungbe, A. D., Parker, N. E., Stephens, A. D., Telfer, P., & Wright, J. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04193.x · Cited by 280
Stroke Prevention Trial in Sickle Cell Anemia
Adams, R. J., McKie, V. C., Brambilla, D., Carl, E., Gallagher, D., Nichols, F. T., Roach, S., Abboud, M., Berman, B., Driscoll, C., et al. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00099-8 · Cited by 278
Self-citationThe paradox of hemoglobin SC disease
Nagel, R. L., Fabry, M. E., & Steinberg, M. H. (2003) · Blood Reviews · doi:10.1016/s0268-960x(03)00003-1 · Cited by 271
Halasa, N. B., Shankar, S. M., Talbot, T. R., Arbogast, P. G., Mitchel, E. F., Wang, W. C., Schaffner, W., Craig, A. S., & Griffin, M. R. (2007) · Clinical Infectious Diseases · doi:10.1086/516781 · Cited by 253
Hydroxyurea in Sickle Cell Disease: Drug Review
Agrawal, R. K., Patel, R. K., shah, V., Nainiwal, L., & Trivedi, B. (2014) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-013-0261-4 · Cited by 252
Estepp, J. H., Smeltzer, M. P., Kang, G., Li, C., Wang, W. C., Abrams, C., Aygun, B., Ware, R. E., Nottage, K., & Hankins, J. S. (2017) · American Journal of Hematology · doi:10.1002/ajh.24906 · Cited by 88
Depression and quality of life in children with sickle cell disease: The effect of social support
Sehlo, M. G., & Kamfar, H. Z. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0461-6 · Cited by 64
Calvet, D., Tuilier, T., Mélé, N., Turc, G., Habibi, A., Abdallah, N. A., Majhadi, L., Hemery, F., Edjlali, M., Galacteros, F., et al. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017005504 · Cited by 21
Metadata
- Authors
- Leikin, S. L., Gallagher, D., Kinney, T. R., Sloane, D., Klug, P., & Rida, W.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 1989-09-01
- Volume
- 84
- Issue
- 3
- Pages
- 500-508
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W4293174344
- Cited by
- 320
- References
- 0
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.